HomeLOVE • CVE
add
Cannara Biotech Inc
Previous close
$0.68
Year range
$0.52 - $1.04
Market cap
61.21M CAD
Avg Volume
22.87K
P/E ratio
11.69
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | May 2024info | Y/Y change |
|---|---|---|
Revenue | 19.54M | 22.64% |
Operating expense | 5.44M | 26.24% |
Net income | 2.02M | -30.91% |
Net profit margin | 10.35 | -43.69% |
Earnings per share | — | — |
EBITDA | 2.96M | -46.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | May 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.46M | 35.66% |
Total assets | 148.77M | 9.89% |
Total liabilities | 67.00M | 10.93% |
Total equity | 81.77M | — |
Shares outstanding | 90.02M | — |
Price to book | 0.75 | — |
Return on assets | 2.57% | — |
Return on capital | 2.92% | — |
Cash Flow
Net change in cash
| (CAD) | May 2024info | Y/Y change |
|---|---|---|
Net income | 2.02M | -30.91% |
Cash from operations | 4.33M | 70.23% |
Cash from investing | -944.20K | 62.92% |
Cash from financing | -1.05M | -873.04% |
Net change in cash | 2.33M | 2,174.07% |
Free cash flow | -1.34M | 31.05% |
About
Founded
2017
Website
Employees
13
